Describes the miraculous breakthroughs scientists have made in the past decade and dispels the many myths and misunderstandings surrounding stem cell research and therapeutic cloning, offering a ...
Geron Corp. operates as a biotechnology company. It develops a telomerase inhibitor, Imetelstat, in hematologic myeloid malignancies. The firm develops therapeutic products for oncology. The company ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results